Evidence map›Paper›PMID 42560484›Full record

ReviewInternational orthopaedics2026

Clinical evolution in the treatment of degenerative cervical myelopathy in Japan: excellence born from necessity.

Hirotaka Chikuda

Abstract readReviewHistorical Article
PubMed Publisher
In one paragraph

Review in International orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hirotaka ChikudaGunma University, Maebashi, Japan. chikudah@gunma-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo commemorate the centennial of the Japanese Orthopaedic Association, this review highlights Japan's pioneering and globally impactful contributions to spinal surgery, focusing specifically on degenerative cervical myelopathy (DCM) as a representative field of clinical excellence born from unique demographic needs.

methodsA comprehensive historical and clinical overview was conducted, tracing the evolutionary path of diagnostic paradigms and posterior decompressive techniques developed by Japanese innovators, driven by a high domestic prevalence of developmental canal stenosis and ossification of the posterior longitudinal ligament (OPLL).

resultsIn the pre-MRI era, clinical necessity fostered a rigorous neurological culture, yielding diagnostic landmarks such as the Hattori classification, the ten second test, and precise level diagnosis criteria. To circumvent the catastrophic complications of conventional laminectomy, Japanese spine surgeons revolutionized global practice by inventing laminoplasty, evolving from Hattori's Z-plasty to Hirabayashi's open-door and Kurokawa's double-door techniques. Recent decades have seen these procedures meticulously refined to preserve cervical alignment and musculature, successfully adapting to an unprecedented super-aged population.

conclusionAs epitomized by the historical breakthroughs in DCM, Japanese spinal innovations have long established universal standards in patient care. At the forefront of a rapidly aging global population, Japanese orthopaedic surgeons remain uniquely positioned to spearhead the next frontier of clinical innovation across the broader field of spinal care.

Indexed as

Cervical VertebraeDecompression, SurgicalOrthopedicsSpinal Cord DiseasesHistory, 20th CenturyHistory, 21st CenturyHumansJapanLaminectomyLaminoplastyOssification of Posterior Longitudinal LigamentCervical canal stenosisDegenerative cervical myelopathy (DCM)DemographicsJapanese Orthopaedic Association (JOA) scoreLaminoplastyOssification of the posterior longitudinal ligament (OPLL)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.